<PAGE> 1
SCHEDULE 13D/A
-------------------------------------------
OMB APPROVAL
-------------------------------------------
OMB Number: 3235-0145
Expires: August 31, 1991
Estimated average burden
hours per response............... 14.90
-------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No.____________)*
BIO-PLEXUS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON SHARES
- --------------------------------------------------------------------------------
(Title of Class of Securities)
B250962
- --------------------------------------------------------------------------------
(CUSIP Number)
HERMAN GROSS, 12 JORDAN DRIVE, GREAT NECK, NY 11021 (516) 487-9579
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
VARIOUS IN NOVEMBER & DECEMBER 1997
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
X-1
<PAGE> 2
REGULATION OF INVESTMENT ADVISERS
CUSIP No. B250962 SCHEDULE 13D Page ____ of ____ Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HERMAN GROSS ###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OWN FUNDS
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 915,668
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
915,668
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.3278
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
INDIVIDUAL
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
X-2
<PAGE> 3
Schedule 13D
Item 1. Security and Issuer
This statement relates to the ________________________________________.
Item 2. Identity and Background
See Item 1 on the Schedule 13D cover page. No other responsive information
is required.
Item 3. Source and Amount of Funds or Other Consideration
Of the __________ shares of ____________ of ________________ owned by _____
________________, _________ were previously owned by __________________ and
_________ were acquired on _______________ for _____ per share (the average of
the closing bid and ask price on _______________). The total purchase price was
________ and is reflected in a note payable to ________________, a copy of which
is attached hereto as Exhibit "A."
Item 4. Purpose of Transaction
The purpose of the transaction is to acquire additional equity securities
of ______________________________________ has historically maintained a majority
interest in __________________ and thereby enjoys the benefit of financial
statement consolidation. _______________________ has disclosed its historical
practice to maintain majority control of ________________ and its intention to
do so in the future in its annual report on Form 10-K under the heading "Certain
Relationships and Related Transactions."
Item 5. Interest in Securities of the Issuer
See Items 7 through 13 of the Schedule 13D cover page.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
None.
Item 7. Material to be Filed as Exhibits
Exhibit "A" - Note Payable.
X-3
<PAGE> 4
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: January 28, 1998 /s/ Herman Gross
-----------------------------------
Signature
Herman Gross
-----------------------------------
Name/Title
X-4
